BioCentury
ARTICLE | Clinical News

Receptos jumps on RADIANCE update for RPC1063

December 6, 2013 1:54 AM UTC

Receptos Inc. (NASDAQ:RCPT) jumped $4.94 (22%) to $27.64 on Thursday after announcing that a DMC recommended continuing the Phase II portion and starting the Phase III portion of the Phase II/III RADI...